Invention Grant
US08278423B2 Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)
有权
针对人类抗Müllerian激素II型受体（AMHR-II）的单克隆抗体及其片段
- Patent Title: Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)
- Patent Title (中): 针对人类抗Müllerian激素II型受体（AMHR-II）的单克隆抗体及其片段
-
Application No.: US12513248Application Date: 2007-10-31
-
Publication No.: US08278423B2Publication Date: 2012-10-02
- Inventor: Isabelle Teulon , André Pelegrin
- Applicant: Isabelle Teulon , André Pelegrin
- Applicant Address: FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Current Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Current Assignee Address: FR Paris
- Agency: Stites & Harbison, PLLC
- Agent B. Aaron Schulman, Esq.
- Priority: EP06291703 20061102
- International Application: PCT/IB2007/003301 WO 20071031
- International Announcement: WO2008/053330 WO 20080508
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K17/00 ; C07K17/14 ; C12P21/08 ; A61K39/395 ; A61K39/00
Abstract:
The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.
Public/Granted literature
Information query
